|
1
|
Echt G, Jepson J, Steel J, Langholz B,
Luxton G, Hernandez W, Astrahan M and Petrovich Z: Treatment of
uterine sarcomas. Cancer. 66:35–39. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kurman RJ, Carcangiu ML, Herrington S and
Young RH: World Health Organization Classification of Tumours of
Female Reproductive Organs. 4th. IARC Press; Lyon, France:
|
|
3
|
Tsukamoto N, Kamura T, Matsukuma K, Imachi
M, Uchino H, Saito T and Ono M: Endolymphatic stromal myosis: A
case with positive estrogen and progesterone receptors and good
response to progestins. Gynecol Oncol. 20:120–128. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sabini G, Chumas JC and Mann WJ: Steroid
hormone receptors in endometrial stromal sarcomas. A biochemical
and immunohistochemical study. Am J Clin Pathol. 97:381–386. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leunen M, Breugelmans M, De Sutter P,
Bourgain C and Amy JJ: Low-grade endometrial stromal sarcoma
treated with the aromatase inhibitor letrozole. Gynecol Oncol.
95:769–771. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pink D, Lindner T, Mrozek A, Kretzschmar
A, Thuss-Patience PC, Dörken B and Reichardt P: Harm or benefit of
hormonal treatment in metastatic low-grade endometrial stromal
sarcoma: Single center experience with 10 cases and review of the
literature. Gynecol Oncol. 101:464–469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaku T, Yoshikawa H, Tsuda H, Sakamoto A,
Fukunaga M, Kuwabara Y, Hataeg M, Kodama S, Kuzuya K, Sato S, et
al: Conservative therapy for adenocarcinoma and atypical
endometrial hyperplasia of the endometrium in young women: Central
pathologic review and treatment outcome. Cancer Lett. 167:39–48.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ushijima K, Yahata H, Yoshikawa H, Konishi
I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, et
al: Multicenter phase II study of fertility-sparing treatment with
medroxyprogesterone acetate for endometrial carcinoma and atypical
hyperplasia in young women. J Clin Oncol. 25:2798–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ishibashi M, Nakayama K, Shamima Y,
Katagiri A, Iida K, Nakayama N and Miyazaki K: Two cases of
endometrial stromal sarcoma (ESS) in which survival was prolonged
by administration of MPA. Gan To Kagaku Ryoho. 35:857–861. 2008.(In
Japanese). PubMed/NCBI
|
|
10
|
Stadsvold JL, Molpus KL, Baker JJ, Michael
K and Remmenga SW: Conservative management of a myxoid endometrial
stromal sarcoma in a 16-year-old nulliparous woman. Gynecol Oncol.
99:243–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amant F, Moerman P, Cadron I, Neven P,
Berteloot P and Vergote I: The diagnostic problem of endometrial
stromal sarcoma: Report on six cases. Gynecol Oncol. 90:37–43.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakayama K, Ishikawa M, Nagai Y, Yaegashi
N, Aoki Y and Miyazaki K: Prolonged long-term survival of low-grade
endometrial stromal sarcoma patients with lung metastasis following
treatment with medroxyprogesterone acetate. Int J Clin Oncol.
15:179–183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shah JP, Bryant CS, Kumar S, Ali-Fehmi R,
Malone JM Jr and Morris RT: Lymphadenectomy and ovarian
preservation in low-grade endometrial stromal sarcoma. Obstet
Gynecol. 112:1102–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thomas MB, Keeney GL, Podratz KC and Dowdy
SC: Endometrial stromal sarcoma: Treatment and patterns of
recurrence. Int J Gynecol Cancer. 19:253–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haberal A, Kayikçioğlu F, Boran N,
Calişkan E, Ozgül N and Köse MF: Endometrial stromal sarcoma of the
uterus: Analysis of 25 patients. Eur J Obstet Gynecol Reprod Biol.
109:209–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Omura GA, Blessing JA, Major F, Lifshitz
S, Ehrlich CE, Mangan C, Beecham J, Park R and Silverberg S: A
randomized clinical trial of adjuvant adriamycin in uterine
sarcomas: A gynecologic oncology group study. J Clin Oncol.
3:1240–1245. 1985.PubMed/NCBI
|
|
17
|
Pautier P, Genestie C, Fizazi K, Morice P,
Mottet C, Haie-Meder C, Le Cesne A and Lhommé C: Cisplatin-based
chemotherapy regimen (DECAV) for uterine sarcomas. Int J Gynecol
Cancer. 12:749–754. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim WY, Lee JW, Choi CH, Kang H, Kim TJ,
Kim BG, Lee JH and Bae DS: Low-grade endometrial stromal sarcoma: A
single center's experience with 22 cases. Int J Gynecol Cancer.
18:1084–1089. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spano JP, Soria JC, Kambouchner M,
Piperno-Neuman S, Morin F, Morere JF, Martin A and Breau JL:
Long-term survival of patients given hormonal therapy for
metastatic endometrial stromal sarcoma. Med Oncol. 20:87–93. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leiser AL, Hamid AM and Blanchard R:
Recurrence of prolactin-producing endometrial stromal sarcoma with
sex-cord stromal component treated with progestin and aromatase
inhibitor. Gynecol Oncol. 94:567–571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Maluf FC, Sabbatini P, Schwartz L, Xia J
and Aghajanian C: Endometrial stromal sarcoma: Objective response
to letrozole. Gynecol Oncol. 82:384–388. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shoji K, Oda K, Nakagawa S, Kawana K,
Yasugi T, Ikeda Y, Takazawa Y, Kozuma S and Taketani Y: Aromatase
inhibitor anastrozole as a second-line hormonal treatment to a
recurrent low-grade endometrial stromal sarcoma: A case report. Med
Oncol. 28:771–774. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chu MC, Mor G, Lim C, Zheng W, Parkash V
and Schwartz PE: Low-grade endometrial stromal sarcoma: Hormonal
aspects. Gynecol Oncol. 90:170–176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piver MS, Rutledge FN, Copeland L, Webster
K, Blumenson L and Suh O: Uterine endolymphatic stromal myosis: A
collaborative study. Obstet Gynecol. 64:173–178. 1984.PubMed/NCBI
|
|
25
|
Katz L, Merino MJ, Sakamoto H and Schwartz
PE: Endometrial stromal sarcoma: A clinicopathologic study of 11
cases with determination of estrogen and progestin receptor levels
in three tumors. Gynecol Oncol. 26:87–97. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scribner DR Jr and Walker JL: Low-grade
endometrial stromal sarcoma preoperative treatment with Depo-Lupron
and Megace. Gynecol Oncol. 71:458–460. 1998. View Article : Google Scholar : PubMed/NCBI
|
